CLDN5 and depressive symptom measurement: We showed that CLDN5 expression is reduced in the NAc of depressed patients (7) in line with clinical studies reporting altered cerebrospinal fluid to serum ratio of peripheral markers in depression indicative of greater BBB permeability (10).